Teva gets patent for invention related to multiple sclerosis drug
April 16, 2016 The company claims that the pharmaceutical composition in the product, related to multiple sclerosis drug Laquinimod, provides…
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
− Strong and Sustained Efficacy of TECFIDERA® Supported by Clinical Data and Real-World Evidence – − New ZINBRYTA™ Data Show Impact…
Stuart Schlossman
Ask the MS Clinician – Topic: ORAL Multiple Sclerosis (MS) Medications
Megan R. Weigel, DNP, ARNP-c, MSCN – expertly answers questions regarding current Oral medications and what looms in the pipelineVideo…
Stuart Schlossman
What You Need To Know About Tecfidera®
Published on Jun 11, 2013 This video was created in June 2013 and features Gabriel Pardo, MD and Bruce Cohen,…
Stuart Schlossman
Gilenya: What is it and How Does it Work?
Uploaded on Oct 20, 2010 MS Learn Online is the National MS Society’s online educational webcast series. This video features…
Stuart Schlossman
Current Disease Modifying Treatments and the Invisible Symptoms of MS – Video Recorded 05.26.15
Program Date: May 26, 2015 – Indianapolis, IN This video recorded program is one of many provided by MS…
Stuart Schlossman
British Columbia Agrees To fund AUBAGIO RRMS Therapy
December 26, 2014 British Columbia’s PharmaCare drug program has announced that it will fund AUBAGIO, a therapy developed by Genzyme for the treatment of multiple sclerosis. AUBAGIO…
Stuart Schlossman
Rare Brain Infection Death Spurs FDA To Update Warning Label for MS Drug
Posted by: Anna Tan, RN November 26, 2014 The US Food and Drug Administration has just issued a report warning the general public and…
Stuart Schlossman
“Lights, Camera, Take Action on MS”
AUBAGIO® is available in 14 mg and 7 mg tablets. Trouble viewing? View as a Web page IMPORTANT SAFETY INFORMATION…
Stuart Schlossman
Biogen and the National MS Society weigh in on the first reported death of an MS patient taking Tecfidera who developed PML.
October 30, 2014 Biogen Idec Inc., maker of the popular multiple sclerosis (MS) pill dimethyl fumarate (Tecfidera), announced the death…
Stuart Schlossman
